By Marshall Hargrave:
Pfizer (NYSE:PFE) tried to buy up AstraZeneca (NYSE:AZN) back in May in an effort to take advantage of the tax inversion craze. But AstraZeneca rejected the bid, noting that the $106.5 billion bid just didn’t fully recognize the company’s value.
read more